comparemela.com

Mary Beth Harler News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IGM Biosciences Announces FDA Clearance to Begin Clinical Studies of Imvotamab in Lupus and Rheumatoid Arthritis

Imvotamab, a CD20 x CD3 bispecific monoclonal antibody, offers potential for deeper B cell depletion than currently approved therapiesMOUNTAIN VIEW, Calif., May 31, 2023 IGM Biosciences, Inc. ,. | May 31, 2023

IGM Biosciences, Inc (NASDAQ:IGMS) Q4 2022 Earnings Call Transcript

vimarsana © 2020. All Rights Reserved.